Abstract
At Hassle we have built a monitoring system in which it is possible to integrate pre and postmarketing data on adverse drug experiences. This article describes the philosophy behind the system as well as the usage of it.
Get full access to this article
View all access options for this article.
References
1.
Skegg
DCG
Doll
R
: The case for recording events in clinical trials . Brit Med J (1977 ); 2 :1523 –1524 .
2.
Vaitonis
SP
Swanger
JC
: An introduction to G. D. Searle's biology reporting system (BRS) . Drug Inf J (1985 ); 1 :69 –74 .
3.
Palmer
L
: Computing in a pharmaceutical company: An unconventional approach . To be published in Drug Inf J.
4.
Venulet
J
: Monitoring adverse drug reactions — The problem of integration of heterogeneous data . Int J of Clin Pharmacol Biopharm (1979 ); 17 :383 –386 .